Immune Sera and Immunoglobulins

DBCAT002143Pharmacologic classJ06

A DrugBank category of 21 drugs. 19 of them are approved.

ATC classification: J — ANTIINFECTIVES FOR SYSTEMIC USE
J06 — IMMUNE SERA AND IMMUNOGLOBULINS
Drugs: Ansuvimab
Bezlotoxumab
Casirivimab
Cilgavimab
Hepatitis B immune globulin
Human cytomegalovirus immune globulin
Human Rho(D) immune globulin
Imdevimab
Motavizumab
Nebacumab
Nirsevimab
Obiltoxaximab
Palivizumab
Rabies virus inactivated antigen, A
Rabies virus inactivated antigen, B
Raxibacumab
Regdanvimab
Sipavibart
Sotrovimab
Tetanus immune globulin, human
Tixagevimab

What you can answer from here — as of August 24, 2016

21DrugsEach linked to its full drug card

Listed above

18Drug targetsEvery drug–target pair in the class, with bond type

360Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Immune Sera and Immunoglobulins share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.